Mohamed A. Ahmed

Mohamed A. Ahmed

Auto-generated profile, based on publicly available information

Mohamed A. Ahmed

American Association For Cancer Research United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2020 in Nature
Verified
Journal Article
Open access
PDF file
JLJaewoong Lee
Jaewoong Lee
MRMark E. Robinson
Mark E. Robinson
NMNing Ma
Ning Ma
DADewan Artadji
Dewan Artadji
MAMohamed A. Ahmed
Mohamed A. Ahmed
MMMarkus Müschen
Markus Müschen
Interferon-induced transmembrane protein 3 (IFITM3) has previously been identified as an endosomal protein that blocks viral infection1,2,3. Here we studied clinical cohorts of patients with B cell leukaemia and lymphoma, and identified IFITM3 as a strong predictor of poor outcome. In normal resting B cells, IFITM3 was minimally expressed and mainly localized in endosomes. However, engagement of the B cell receptor (BCR) induced both expression of IFITM3 and phosphorylation of this protein at Tyr20, which resulted in the accumulation of IFITM3 at the cell surface. In B cell leukaemia, oncogenic kinases phosphorylate IFITM3 at Tyr20, which causes constitutive localization of this protein at the plasma membrane. In a mouse model, Ifitm3−/− naive B cells developed in normal numbers; however, the formation of germinal centres and the production of antigen-specific antibodies were compromised. Oncogenes that induce the development of leukaemia and lymphoma did not transform Ifitm3−/− B cells. Conversely, the phosphomimetic IFITM3(Y20E) mutant induced oncogenic PI3K signalling and initiated the transformation of premalignant B cells. Mechanistic experiments revealed that IFITM3 functions as a PIP3 scaffold and central amplifier of PI3K signalling. The amplification of PI3K signals depends on IFITM3 using two lysine residues (Lys83 and Lys104) in its conserved intracellular loop as a scaffold for the accumulation of PIP3. In Ifitm3−/− B cells, lipid rafts were depleted of PIP3, which resulted in the defective expression of over 60 lipid-raft-associated surface receptors, and impaired BCR signalling and cellular adhesion. We conclude that the phosphorylation of IFITM3 that occurs after B cells encounter antigen induces a dynamic switch from antiviral effector functions in endosomes to a PI3K amplification loop at the cell surface. IFITM3-dependent amplification of PI3K signalling, which in part acts downstream of the BCR, is critical for the rapid expansion of B cells with high affinity to antigen. In addition, multiple oncogenes depend on IFITM3 to assemble PIP3-dependent signalling complexes and amplify PI3K signalling for malignant transformation.

22 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
LCLai N. Chan
Lai N. Chan
MMMark A. Murakami
Mark A. Murakami
MRMark E. Robinson
Mark E. Robinson
RCRebecca Caeser
Rebecca Caeser
TSTeresa Sadras
Teresa Sadras
MMMarkus Müschen
Markus Müschen

17 September 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
MAMohamed A. Ahmed
Mohamed A. Ahmed
ESEdgar Selzer
Edgar Selzer
WDWolfgang Dörr
Wolfgang Dörr
GJGerd Jomrich
Gerd Jomrich
FHFelix Harpain
Felix Harpain
Brigitte MarianBrigitte Marian
Brigitte Marian
Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer

8 January 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
MAMohamed A. Ahmed
Mohamed A. Ahmed
COCarol O'CAllaghan
Carol O'CAllaghan
ECElliot D. Chang
Elliot D. Chang
HJHaiyan Jiang
Haiyan Jiang
AVAthanassios Vassilopoulos
Athanassios Vassilopoulos
Calorie restriction (CR) is considered one of the most robust ways to extend life span and reduce the risk of age-related diseases, including cancer, as shown in many different organisms, whereas opposite effects have been associated with high fat diets (HFDs). Despite the proven contribution of sirtuins in mediating the effects of CR in longevity, the involvement of these nutrient sensors, specifically, in the diet-induced effects on tumorigenesis has yet to be elucidated. Previous studies focusing on SIRT1, do not support a critical role for this sirtuin family member in CR-mediated cancer prevention. However, the contribution of other family members which exhibit strong deacetylase activity is unexplored. To fill this gap, we aimed at investigating the role of SIRT2 and SIRT3 in mediating the anti and pro-tumorigenic effect of CR and HFD, respectively. Our results provide strong evidence supporting distinct, context-dependent roles played by these two family members. SIRT2 is indispensable for the protective effect of CR against tumorigenesis. On the contrary, SIRT3 exhibited oncogenic properties in the context of HFD-induced tumorigenesis, suggesting that SIRT3 inhibition may mitigate the cancer-promoting effects of HFD. Given the different functions regulated by SIRT2 and SIRT3, unraveling downstream targets/pathways involved may provide opportunities to develop new strategies for cancer prevention.

1 October 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
FHFelix Harpain
Felix Harpain
MAMohamed A. Ahmed
Mohamed A. Ahmed
XHXenia Hudec
Xenia Hudec
GTGerald Timelthaler
Gerald Timelthaler
GJGerd Jomrich
Gerd Jomrich
GSGerd R. Silberhumer
Gerd R. Silberhumer
Purpose Therapy response to neoadjuvant radiochemotherapy (nRCT) of locally advanced rectal cancer varies widely so that markers predicting response are urgently needed. Fibroblast growth factor (FGF) and FGF receptor (FGFR) signaling is involved in pro-survival signaling and thereby may result in radiation resistance. Methods In a cohort of 43 rectal cancer patients, who received nRCT, we analyzed protein levels of FGF 8 and its downstream target Survivin by immunohistochemistry to assess their impact on nRCT response. In vitro resistance models were created by exposing colorectal cancer cell lines to fractionated irradiation and selecting long-term survivors. Results Our findings revealed significantly higher FGF8 and Survivin staining scores in pre-treatment biopsies as well as in surgical specimens of non-responsive compared to responsive patients. Functional studies demonstrated dose-dependent induction of FGF8 mRNA expression in mismatch-incompetent DLD1 cells already after one dose of irradiation. Surviving clones after one or two series of radiation were more resistant to an additional radiation fraction than non-irradiated controls and showed a significant increase in expression of the FGF8 receptor FGFR3 and of Survivin on both the RNA and the protein levels. Conclusion The results of this study suggest that FGF8 and Survivin contribute to radiation resistance in rectal cancer and may serve as markers to select patients who may not benefit from neoadjuvant radiotherapy.

1 October 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
HKHong-Jun Kang
Hong-Jun Kang
HSHa Yong Song
Ha Yong Song
MAMohamed A. Ahmed
Mohamed A. Ahmed
YGYang Guo
Yang Guo
MZMingming Zhang
Mingming Zhang
AVAthanassios Vassilopoulos
Athanassios Vassilopoulos
Previous studies have shown that SIRT2 plays a role in mitosis through deacetylating specific downstream targets. However, the upstream regulation of SIRT2 activity has been relatively unexplored. In this study, we provide evidence that NAD(P)H:quinone oxidoreductase 1 (NQO1) interacts with and activates SIRT2 in an NAD-dependent manner. Strong protein-protein interaction and co-localization of the two proteins during mitosis is required to maintain an active NQO1-SIRT2 axis which is critical for successful completion of mitosis. This is evident by the observed delay in mitotic exit in cells upon NQO1 inhibition. Mechanistically, this phenotype can be explained by the decrease in APC/C complex activity resulting from decreased SIRT2 deacetylation activity. Furthermore, we show that this newly established role of NQO1 has an impact on how cancer cells may respond to mitotic stress. In this regard, both pharmacologic and genetic NQO1 inhibition increases sensitivity to anti-mitotic drugs functioning as microtubule poisons by inducing mitotic arrest and allowing cells to accumulate cell death signals. Therefore, the significant prognostic value of NQO1 in predicting outcome of cancer patients might be explained in part due to the functional contribution of NQO1-SIRT2 axis to mitotic stress. Altogether, this novel mechanism of action further supports the pleiotropic biological effects exerted by NQO1 in addition to its antioxidant function and it might provide the basis for expanding the therapeutic potential of NQO1 inhibition towards increasing sensitivity to standard treatments.